Literature DB >> 11530302

Immunology and the REACH study: HIV immunology and preliminary findings. Reaching for Excellence in Adolescent Care and Health.

B J Rudy1, P A Crowley-Nowick, S D Douglas.   

Abstract

This review paper presents the immunology findings in human immunodeficiency virus (HIV) infected and uninfected youth in the Reaching for Excellence in Adolescent Care and Health (REACH) Project within the context of basic and HIV immunology concepts. Methods employed in the study for specimen collection, management, and laboratory analysis are presented. This paper reviews published analyses of cross-sectional data; longitudinal analyses are underway. These preliminary data extend the work of others in demonstrating the potential for substantial thymic reserve in youth. This finding in HIV infected adolescents has implications for a fuller response to antiretroviral or immune-based therapies compared to that seen in adults. Dysregulation in mucosal immunity may appear before systemic HIV effects are seen and requires attention particularly to screening and treatment of genital co-infections. REACH has demonstrated gender differences in immunologic measures irrespective of HIV infection status.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11530302     DOI: 10.1016/s1054-139x(01)00288-9

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  7 in total

1.  Assessment of thymic activity in human immunodeficiency virus-negative and -positive adolescents by real-time PCR quantitation of T-cell receptor rearrangement excision circles.

Authors:  Thao Pham; Marvin Belzer; Joseph A Church; Christina Kitchen; Craig M Wilson; Steven D Douglas; Yongzhi Geng; Monica Silva; Richard M Mitchell; Paul Krogstad
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

2.  Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061.

Authors:  Bret J Rudy; Bill G Kapogiannis; Carol Worrell; Kathleen Squires; James Bethel; Su Li; Craig M Wilson; Allison Agwu; Patricia Emmanuel; Georgine Price; Stephanie Hudey; Maureen M Goodenow; John W Sleasman
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

3.  TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths.

Authors:  Steven D Douglas; Stephen Durako; Kathleen E Sullivan; Margaret Camarca; Anna-Barbara Moscicki; Craig M Wilson
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

4.  Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.

Authors:  Salma S Syed; Rula S Balluz; Edmond K Kabagambe; William A Meyer; Susan Lukas; Craig M Wilson; Bill G Kapogiannis; Sharon A Nachman; John W Sleasman
Journal:  AIDS Res Hum Retroviruses       Date:  2012-12-03       Impact factor: 2.205

5.  Soluble CD14, CD163, and CD27 biomarkers distinguish ART-suppressed youth living with HIV from healthy controls.

Authors:  Julie C Williams; Xinrui Zhang; Manju Karki; Yueh-Yun Chi; Shannon M Wallet; Bret J Rudy; Sharon L Nichols; Maureen M Goodenow; John W Sleasman
Journal:  J Leukoc Biol       Date:  2018-01-29       Impact factor: 4.962

6.  Notification of HIV status disclosure and its related factors in HIV-infected adolescents in 2009 in the Aconda program (CePReF, CHU Yopougon) in Abidjan, Côte d'Ivoire, The PRADO-CI Study.

Authors:  Guanga David Meless; Hortense Aka-Dago-Akribi; Chantal Cacou; Tanoh François Eboua; Addi Edmond Aka; Aimé Maxime Oga; Belinda Bouah; Messou Eugène; Corinne Moh; Elise Arrivé; Marguerite Timité-Konan; Valériane Leroy
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

7.  HIV in Adolescents.

Authors:  Marina Catallozzi; Donna C Futterman
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.663

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.